Sei Investments Co. Trims Position in Inspire Medical Systems, Inc. $INSP

Sei Investments Co. lessened its holdings in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 17.4% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 42,100 shares of the company’s stock after selling 8,840 shares during the quarter. Sei Investments Co. owned approximately 0.15% of Inspire Medical Systems worth $2,171,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. State of Wyoming increased its position in Inspire Medical Systems by 83.7% during the 1st quarter. State of Wyoming now owns 1,343 shares of the company’s stock valued at $69,000 after purchasing an additional 612 shares during the period. First Trust Advisors LP lifted its position in shares of Inspire Medical Systems by 2,232.7% in the 1st quarter. First Trust Advisors LP now owns 71,661 shares of the company’s stock worth $3,696,000 after purchasing an additional 68,589 shares during the period. Principal Financial Group Inc. boosted its stake in shares of Inspire Medical Systems by 1.0% during the 1st quarter. Principal Financial Group Inc. now owns 126,788 shares of the company’s stock valued at $6,540,000 after purchasing an additional 1,269 shares in the last quarter. Fifth Third Bancorp boosted its stake in shares of Inspire Medical Systems by 1,794.4% during the 1st quarter. Fifth Third Bancorp now owns 6,441 shares of the company’s stock valued at $332,000 after purchasing an additional 6,101 shares in the last quarter. Finally, New York State Teachers Retirement System increased its position in shares of Inspire Medical Systems by 9.3% during the first quarter. New York State Teachers Retirement System now owns 23,599 shares of the company’s stock valued at $1,217,000 after buying an additional 2,004 shares during the period. Hedge funds and other institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Stock Performance

Shares of INSP opened at $60.12 on Friday. Inspire Medical Systems, Inc. has a fifty-two week low of $38.91 and a fifty-two week high of $147.03. The firm’s 50-day simple moving average is $47.64 and its two-hundred day simple moving average is $54.51. The stock has a market cap of $1.74 billion, a PE ratio of 13.01, a price-to-earnings-growth ratio of 4.57 and a beta of 0.70.

Inspire Medical Systems (NYSE:INSP) last released its earnings results on Monday, August 3rd. The company reported $0.14 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.24) by $0.38. Inspire Medical Systems had a net margin of 15.03% and a return on equity of 8.64%. The firm had revenue of $200.58 million during the quarter, compared to analyst estimates of $194.72 million. During the same period last year, the business earned $0.45 earnings per share. The business’s revenue was down 7.6% on a year-over-year basis. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. Equities research analysts predict that Inspire Medical Systems, Inc. will post 1.24 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on INSP shares. Wells Fargo & Company decreased their price target on shares of Inspire Medical Systems from $70.00 to $56.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 5th. Truist Financial reiterated a “hold” rating and set a $62.00 target price (up from $54.00) on shares of Inspire Medical Systems in a report on Tuesday. Freedom Capital raised Inspire Medical Systems to a “strong-buy” rating in a research report on Tuesday, June 30th. Robert W. Baird raised their target price on Inspire Medical Systems from $54.00 to $59.00 and gave the company a “neutral” rating in a research note on Tuesday, August 4th. Finally, Summit Redstone set a $39.00 price target on Inspire Medical Systems in a research report on Friday, May 22nd. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, thirteen have issued a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $68.00.

About Inspire Medical Systems

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.